Company Description
Concentra Group Holdings Parent, Inc. provides occupational health services in the United States.
The company offers occupational and consumer health services, including workers compensation, employer services and consumer health services, employer-sponsored primary care services at workplace, including mobile health services, and episodic specialty testing services several complementary services include Concentra Telemed, a telemedicine solution for the treatment of work-related injuries and illnesses, and employer services; pharmacy solution under the Concentra Pharmacy name; and Concentra Medical Compliance Administration, a third-party administrator that helps to manage abuse testing programs for employers with regulated or non-regulated workforces.
It also provides injury care, primary care, urgent care, preventive care, clinical testing, physical examinations and evaluations, drug and alcohol screenings, clinical testing, vaccinations and other preventive care, and a range of consultative services designed to protect employees from workplace hazards, as well as wellness programs through occupational health centers and onsite clinics.
The company was founded in 1979 and is based in Mechanicsburg, Pennsylvania. Concentra Group Holdings Parent, Inc. is a subsidiary of Select Medical Corporation.
Country | United States |
Founded | 1979 |
IPO Date | Jul 25, 2024 |
Industry | Medical Care Facilities |
Sector | Healthcare |
Employees | 8,856 |
CEO | William Newton |
Contact Details
Address: 4714 Gettysburg Road Mechanicsburg, Pennsylvania 17055 United States | |
Phone | 717 972 1100 |
Website | concentra.com |
Stock Details
Ticker Symbol | CON |
Exchange | NYSE |
Stock Type | Common Stock |
Fiscal Year | January - December |
Reporting Currency | USD |
IPO Price | $23.50 |
CIK Code | 0002014596 |
CUSIP Number | 20603L102 |
ISIN Number | US20603L1026 |
Employer ID | 30-1006613 |
SIC Code | 8093 |
Key Executives
Name | Position |
---|---|
William Keith Newton | Chief Executive Officer and Director |
Matthew T. DiCanio M.B.A., MBA | President and Chief Financial Officer |
Su Zan Nelson CPA, CPA | Executive Vice President and Chief Accounting Officer |
John A. deLorimier | Executive Vice President and Chief Information and Technology Officer |
Giovanni Gallara | Executive Vice President and Chief Clinical Services Officer |
Timothy F. Ryan | Executive Vice President and Chief Legal Counsel |
Thomas A. Devasia | Executive Vice President and Chief Marketing and Innovation Officer |
Danielle Kendall | Executive Vice President and Chief People Officer |
Dr. John R. Anderson DO, FACOEM | Executive Vice President and Chief Medical Officer |
Michael A. Kosuth | Executive Vice President and Chief Operating Officer of East |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Mar 18, 2025 | ARS | Filing |
Mar 18, 2025 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
Mar 18, 2025 | DEF 14A | Other definitive proxy statements |
Mar 4, 2025 | SCHEDULE 13D/A | Filing |
Mar 4, 2025 | SCHEDULE 13D/A | Filing |
Mar 3, 2025 | 10-K | Annual Report |
Mar 3, 2025 | 8-K | Current Report |
Feb 14, 2025 | SCHEDULE 13G | Filing |
Jan 30, 2025 | SCHEDULE 13G | Filing |
Jan 23, 2025 | 8-K | Current Report |